Advanced search
Publication Cover
Leukemia & Lymphoma Volume 61, 2020 - Issue 3
Submit an article Journal homepage
803
Views
3
CrossRef citations to date
0
Altmetric
Original Articles

A matching-adjusted indirect treatment comparison (MAIC) of daratumumab–bortezomib–melphalan–prednisone (D-VMP) versus lenalidomide–dexamethasone continuous (Rd continuous), lenalidomide–dexamethasone 18 months (Rd 18), and melphalan–prednisone–thalidomide (MPT)

Meletios A. DimopoulosDepartment of Clinical Therapeutics, National and Kapodistrian University of Athens, Athens, Greece; Correspondence[email protected]
ORCID Iconhttp://orcid.org/0000-0001-8990-3254View further author information
ORCID Icon,
Michele CavoDepartment of Experimental, Diagnostic and Specialty Medicine, “Seragnoli” Institute of Hematology, University of Bologna, Bologna, Italy; View further author information
,
Maria-Victoria MateosDepartment of Hematology, University Hospital of Salamanca/IBSAL, Salamanca, Spain; ORCID Iconhttp://orcid.org/0000-0003-2390-1218View further author information
ORCID Icon,
Thierry FaconDepartment of Hematology, University of Lille, CHU Lille, Service des Maladies du Sang, Lille, France; View further author information
,
Bart HeegIngress Health, Rotterdam, The Netherlands; ORCID Iconhttp://orcid.org/0000-0002-9226-3232View further author information
ORCID Icon,
Sophie van BeekhuizenIngress Health, Rotterdam, The Netherlands; View further author information
,
Samron B. GebregergishIngress Health, Rotterdam, The Netherlands; View further author information
,
Sandhya NairJanssen Research and Development, Beerse, Belgium; View further author information
,
Marta PisiniJanssen, EMEA, Beerse, Belgium; View further author information
,
Annette LamJanssen Global Services, Raritan, NJ, USAORCID Iconhttp://orcid.org/0000-0003-2037-3464View further author information
ORCID Icon &
Mary SlavcevJanssen Global Services, Raritan, NJ, USAView further author information
 show all
Pages 714-720 | Received 28 Jun 2019, Accepted 13 Oct 2019, Published online: 05 Nov 2019

Citations (3)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (1)

Pellegrino Musto & Francesco La Rocca. (2020) Monoclonal antibodies in newly diagnosed and smoldering multiple myeloma: an updated review of current clinical evidence. Expert Review of Hematology 13:5, pages 501-517.
Read now

Articles from other publishers (2)

Philippe Moreau, Benjamin Hebraud, Thierry Facon, Xavier Leleu, Cyrille Hulin, Mahmoud Hashim, Yannan Hu, Denis Caillot, Lofti Benboubker, Sonja Zweegman, Maximilian Merz, Katja Weisel, Hans Salwender, Elias K Mai, Hartmut Goldschmidt, Uta Bertsch, Véronique Vanquickelberghe, Tobias Kampfenkel, Carla de Boer, Stanimira Krotneva, Irina Proskorovsky, Jianming He, Annette Lam, Charlene Lee, Sarah Cote & Pieter Sonneveld. (2021) Front-line daratumumab-VTd versus standard-of-care in ASCT-eligible multiple myeloma: matching-adjusted indirect comparison. Immunotherapy 13:2, pages 143-154.
Crossref
Pieter Sonneveld, María‐Victoria Mateos, Adrian Alegre, Thierry Facon, Cyrille Hulin, Mahmoud Hashim, Talitha Vincken, Tobias Kampfenkel, Sarah Cote, Jianming He, Annette Lam & Philippe Moreau. (2020) Matching‐adjusted indirect comparison of efficacy and safety of bortezomib, thalidomide, and dexamethasone (VTd) as per label compared with modified VTd dosing schedules in patients with newly diagnosed multiple myeloma who are transplant eligible. eJHaem 1:2, pages 481-488.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.